Metastatik meme kanserlerinde radyoterapi

Meme kanserli hastaların %25-40ında hastalık süreci boyunca metastazgelişmektedir. Metastatik meme kanserinde prognoz pek çok faktöre bağlıolarak değişmektedir. Her hasta için bireysel değerlendirme ve tedavi kararıönemlidir. Oligometastatik olarak nitelendirilen, soliter veya birkaç tanemetastatik lezyonu olan genç yaşta ve performansı iyi olan metastatik memekanserli hastaların lokal (meme ve lenfatik) tedavisinde günümüz içinönerilen tedavi cerrahi ve/veya radyoterapidir. Kemik metastazları ya dabeyin metastazları olan hastalarda, farklı fraksinasyon şemaları ileuygulanabilen lokal radyoterapi ile oldukça etkin semptom palyasyonusağlanabilmektedir.

Radiation therapy in metastatic breast cancer

Metastasis develops in 25-40% of breast cancer patients beyond their disease process. The prognosis of metastatic breast cancer differs depending on various factors. The evaluation of the patient and the decision of the treatment must be individualized. Locally treatment of oligometastatic breast cancer is, radical treatment including surgery and/or radiation therapy, if the patient has good performance status. Radiation therapy which can be applied with different fractionation schedules and dose concepts, provides effective symptom palliation on patients with bone or brain metastasis.

PDF

___

1. Maughan KL, Lutterbie MA, Ham SP.Treatment of Breast Cancer.American Family Physician 2010;81:1339-46.
2. Guarneri V, Franco P. The curability of breast cancer and the treatment of advanced disease. ConteEuropean Journal of Nuclear Medicine and Molecular Imaging. 2004;31:149-61.
3. Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, et al. International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? 2010;102:456-63.
4. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer 2004;100:4452.
5. Hanrahan EO, Broglio KR, Buzdar AU, Theriault RL, Valero V, Cristofanilli M, et al. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors. Cancer 2005;104:115871.
6. Nieto Y, Cagnoni PJ, Shpall EJ, Matthes S, Barón A, Jones RB, et al. Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease. Clin Cancer Res 1999;5:17317.
7. Clavel M. Management of breast cancer with bone metastases. Bone 1991;12:11-2.
8. Vassiliou V, Kalogeropoulou C, Christopoulos C, Solomou E, Leotsinides M, Kardamakis D. Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment. Int J Radiat Oncol Biol Phys 2007;67:264-72.
9 Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose- fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605.
10. Halperin EC, Perez CA, Brady LW. Principles and Practice of Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2008:1986- 1999.
11. Saarto T, Janes R, Tenhunen M, Kouri M. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 2002;6:32330.
12. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 2003; 15:345-52.
13. Delozier T. Radiotherapie palliative des metastases osseuses; J Eur Radiother 1984;2: 99-104.
14. Koswig S, Buchali A, Böhmer D, Schlenger L, Budach V. Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients. Strahlenther Onkol 1999;175:509-14.
15. Douglas P, Rossier P, Mirimanoff R-O, Coucke PA. Third-body irradiation as an effective palliative treatment for painful multipl bone metastases resistant to chemo or hormonal treatment. Radiotherapy and Oncology 1993;28:76-8.
16. Price P, Hoskin PJ, Easton D, Austin D, Palmer S, Yarnold JR. Low dose single fraction radiotherapy in the treatment of metastatic bone pain: A pilot study. Radiother Oncol 1988;12:297-300.
17. Dirier A, Karadayı B. Kemik Metastazı Yapmış Meme Kanserli Hastaların Tedavi Sonuçları. Dicle Tıp Dergisi 2006; 33:8-10.
18. Hoskin PJ, Price P, Easton D, Regan J, Austin D, Palmer S, Yarnold JR. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiotherapy and Oncology 1992;23:74-8.
19. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-9.
20. Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 1985;55:1468-72.
21.Rasmusson B, Vejborg I, Jensen AB. Irradiation of bone metastases in breast cancer patients: a randomized study with l year follow up. Radiotherapy and Oncology 1995;34: 179-84.
22. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101-9.
23. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005; 97:798804.
24. Koswig S, Budach V. Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 1999;175:500-8.
25. Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, et al. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. Radiother Oncol 2006;79:278-84.
26. Foro Arnalot P, Fontanals AV, Galcerán JC, Lynd F, Latiesas XS, de Dios NR, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 2008; 89:1505.
27. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy: A systemic review of randomized trials. Clin Oncol 2003;15:345-52.
28. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007;25:142336.
29. Feyer P, Sautter-Bihl ML, Budach W, Dunst J, Haase W, Harms W, et al. DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol 2010;186:63-9.
30. Loblaw DA, Wu JS, Kirkbride P, Panzarella T, Smith K, Aslanidis J, et al. Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial. Support Care Cancer 2007;15:451-5.
31. Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, et al. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 1986;58:29-36.
32. Sarin R, Budrukkar A. Efficacy, toxicity, and cost-effectiveness of single- dose versus fractionated hemibody irradiation (HBI). Int J Radiat Oncol Biol Phys 2002;52:1146; author reply 1146-7.
33. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006;3:CD003869.
34. Posner JB. Management of central nervous system metastases . Seminars in Oncology 1977;4: 8191.
35. Hart MG, Grant R, Walker M, Dickinson H. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. Cochrane Database Syst Rev 2005;1:CD003292.
36. Lim LC, Rosenthal MA, Maartens N and Ryan G. Management of brain metastases. Internal Medicine Journal 2004;34: 270-84.
37. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9.
38. Haie-Meder C, Pellae-Cosset B, Laplanche A, Lagrange JL, Tuchais C, Nogues C, et al. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 1993;26:111-6.
39. Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al. A randomized phase III study of accelerated hyperfractionation versus Standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:5714.
40. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996;8:308-15.
41. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:74551.
42. Mehta MP, Tsao MN, Whelan TJ. The American Society for Therapeutic Raiology and Oncology (ASTRO) Evidence-based Review of the role of Radiosurgery for Brain Metastases. Int J Radiation Oncology Biol Phys 2005; 63:37-46.
43. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radios urgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases . International Journal of Radiation Oncology Biology Physics 1999;45:427-34.
44. Andrews DW, Scott CB, Sperduto PW, Flanders AE , Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without s tereotactic radiosurgery boost for patients with one to three brain metastases:phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1665-72.
45. Chougule PB, Burton-Williams M, Saris S, Zheng Z, Ponte B, Noren G, et al.Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. International Journal of Radiation Oncology, Biology, Physics 2000;48(3S):114.
46. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation induced encephalopathy. J Clin Oncol 1994;12: 62742.